These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 22396310)

  • 41. Myotonia in DNM2-related centronuclear myopathy.
    Dabby R; Sadeh M; Gilad R; Jurkat-Rott K; Lehmann-Horn F; Leshinsky-Silver E
    J Neural Transm (Vienna); 2014 May; 121(5):549-53. PubMed ID: 24366529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A rare case of centronuclear myopathy with
    Aghbolaghi AG; Lechpammer M
    Autops Case Rep; 2017; 7(2):43-48. PubMed ID: 28740838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Respiratory features of centronuclear myopathy in the Netherlands.
    Bouma S; Cobben N; Bouman K; Gaytant M; van de Biggelaar R; van Doorn J; Reumers SFI; Voet NB; Doorduin J; Erasmus CE; Kamsteeg EJ; Jungbluth H; Wijkstra P; Voermans NC
    Neuromuscul Disord; 2023 Jul; 33(7):580-588. PubMed ID: 37364426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dynamin 2 mutants linked to centronuclear myopathies form abnormally stable polymers.
    Wang L; Barylko B; Byers C; Ross JA; Jameson DM; Albanesi JP
    J Biol Chem; 2010 Jul; 285(30):22753-7. PubMed ID: 20529869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Centronuclear myopathies: a widening concept.
    Romero NB
    Neuromuscul Disord; 2010 Apr; 20(4):223-8. PubMed ID: 20181480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dynamin 2 mutations in Charcot-Marie-Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination.
    Sidiropoulos PN; Miehe M; Bock T; Tinelli E; Oertli CI; Kuner R; Meijer D; Wollscheid B; Niemann A; Suter U
    Brain; 2012 May; 135(Pt 5):1395-411. PubMed ID: 22451505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy.
    Ceyhan-Birsoy O; Agrawal PB; Hidalgo C; Schmitz-Abe K; DeChene ET; Swanson LC; Soemedi R; Vasli N; Iannaccone ST; Shieh PB; Shur N; Dennison JM; Lawlor MW; Laporte J; Markianos K; Fairbrother WG; Granzier H; Beggs AH
    Neurology; 2013 Oct; 81(14):1205-14. PubMed ID: 23975875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenotype variability and histopathological findings in patients with a novel DNM2 mutation.
    Chen S; Huang P; Qiu Y; Zhou Q; Li X; Zhu M; Hong D
    Neuropathology; 2018 Feb; 38(1):34-40. PubMed ID: 28971531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement.
    Schessl J; Medne L; Hu Y; Zou Y; Brown MJ; Huse JT; Torigian DA; Jungbluth H; Goebel HH; Bönnemann CG
    Neuromuscul Disord; 2007 Jan; 17(1):28-32. PubMed ID: 17134899
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model.
    Fongy A; Falcone S; Lainé J; Prudhon B; Martins-Bach A; Bitoun M
    Sci Rep; 2019 Feb; 9(1):1580. PubMed ID: 30733559
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Allele-specific silencing therapy for Dynamin 2-related dominant centronuclear myopathy.
    Trochet D; Prudhon B; Beuvin M; Peccate C; Lorain S; Julien L; Benkhelifa-Ziyyat S; Rabai A; Mamchaoui K; Ferry A; Laporte J; Guicheney P; Vassilopoulos S; Bitoun M
    EMBO Mol Med; 2018 Feb; 10(2):239-253. PubMed ID: 29246969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel mutation in the dynamin 2 gene in a Charcot-Marie-Tooth type 2 patient: clinical and pathological findings.
    Bitoun M; Stojkovic T; Prudhon B; Maurage CA; Latour P; Vermersch P; Guicheney P
    Neuromuscul Disord; 2008 Apr; 18(4):334-8. PubMed ID: 18394888
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies.
    Toussaint A; Cowling BS; Hnia K; Mohr M; Oldfors A; Schwab Y; Yis U; Maisonobe T; Stojkovic T; Wallgren-Pettersson C; Laugel V; Echaniz-Laguna A; Mandel JL; Nishino I; Laporte J
    Acta Neuropathol; 2011 Feb; 121(2):253-66. PubMed ID: 20927630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical, genetic, and histological features of centronuclear myopathy in the Netherlands.
    Reumers SFI; Erasmus CE; Bouman K; Pennings M; Schouten M; Kusters B; Duijkers FAM; van der Kooi A; Jaeger B; Verschuuren-Bemelmans CC; Faber CG; van Engelen BG; Kamsteeg EJ; Jungbluth H; Voermans NC
    Clin Genet; 2021 Dec; 100(6):692-702. PubMed ID: 34463354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Centronuclear myopathy related to dynamin 2 mutations: clinical, morphological, muscle imaging and genetic features of an Italian cohort.
    Catteruccia M; Fattori F; Codemo V; Ruggiero L; Maggi L; Tasca G; Fiorillo C; Pane M; Berardinelli A; Verardo M; Bragato C; Mora M; Morandi L; Bruno C; Santoro L; Pegoraro E; Mercuri E; Bertini E; D'Amico A
    Neuromuscul Disord; 2013 Mar; 23(3):229-38. PubMed ID: 23394783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impaired excitation-contraction coupling in muscle fibres from the dynamin2
    Kutchukian C; Szentesi P; Allard B; Trochet D; Beuvin M; Berthier C; Tourneur Y; Guicheney P; Csernoch L; Bitoun M; Jacquemond V
    J Physiol; 2017 Dec; 595(24):7369-7382. PubMed ID: 29071728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Centronuclear Myopathy Caused by Defective Membrane Remodelling of Dynamin 2 and BIN1 Variants.
    Fujise K; Noguchi S; Takeda T
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease.
    Fabrizi GM; Ferrarini M; Cavallaro T; Cabrini I; Cerini R; Bertolasi L; Rizzuto N
    Neurology; 2007 Jul; 69(3):291-5. PubMed ID: 17636067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mutations in dynamin 2 cause dominant centronuclear myopathy].
    Bitoun M; Romero NB; Guicheney P
    Med Sci (Paris); 2006 Feb; 22(2):101-2. PubMed ID: 16457739
    [No Abstract]   [Full Text] [Related]  

  • 60. Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice.
    Tasfaout H; Buono S; Guo S; Kretz C; Messaddeq N; Booten S; Greenlee S; Monia BP; Cowling BS; Laporte J
    Nat Commun; 2017 Jun; 8():15661. PubMed ID: 28589938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.